Drawing for INDUCT

USPTO serial 76093867

INDUCT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
RUPP, BRIAN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with INDUCT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

E. Lynn Perry

E LYNN PERRY TOWNSEND AND TOWNSEND AND CREW, LLPTWO EMBARCADERO CTR 8TH FLSAN FRANCISCO, CA 94111-3834UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical supply kits containing chemical agents for use in the diagnosis and treatment of breast cancer; diagnostic preparations for clinical and medical laboratory use, prophylactic chemical compositions and therapeutic chemical compositions for breast cancer and breast precancer diagnosis and treatment and/or chemical reagents for diagnostic and clinical use in the treatment and prevention of breast cancer; medical supply kits containing chemical reagents for use in the diagnosis and treatment of breast cancerABANDONED—
010Medical devices for breast cancer and breast precancer diagnosis and treatment and for diagnosis and treatment of other breast conditions, namely, catheters, stents, aspirator cups, dilators, and other tools for performing breast duct access, namely breast duct access catheters, microcatheters, stents, dilators, endoscopes, ductoscopes, nipple aspirators, and generally breast duct access devices for access, fluid infusion and fluid retrieval; medical equipment for use in fluid infusion and fluid retrieval from the breast duct; medical supply kits containing tools, namely, breast duct access catheters, microcatheters, stents, dilators, endoscopes, ductoscopes, nipple aspirators, and generally breast duct access devices for access, fluid infusion and fluid retrieval, to perform diagnosis and treatment of breast cancerABANDONED—
041Educational services, namely, conducting classes, seminars, conferences, workshops training sessions in the field of breast cancer diagnosis and treatment and breast pre-cancer diagnosis and treatmentABANDONED—
042Breast cancer and breast precancer diagnosis and treatment; diagnosis and treatment of other medical conditions of the breast, namely, breast cancer and breast precancer; diagnostic testing, prognostic testing, monitoring of an identified medical cellular and molecular condition in the breast, cytological analysis of cells retrieved from a breast duct, focused prophylactic or therapeutic treatments for breast cancer, precancer, and other identified breast conditions, namely benign conditions such as ductal absess, cysts, papilloma, and other abnormal non-malignant conditions of the breastABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 24, 2003ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Feb 24, 2003OP.TOPPOSITION TERMINATED NO. 999999—
Feb 24, 2003OP.SOPPOSITION SUSTAINED NO. 999999—
Jun 6, 2002OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 6, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Feb 5, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 16, 2002NPUBNOTICE OF PUBLICATION—
Oct 25, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 22, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance